News report courtesy Forum Communication, written by Barry Amundson. Published August 29, 2019
Tax incentive supporters are putting the pressure on to show that programs being offered to businesses and developers are not only going to eventually provide impressive property tax payments but also provide positive ripple effects in the community.
Sickle cell disease (SCD) is a common inherited blood disorder, affecting 70,000 to 80,000 Americans, with approximately 300,000 babies born each year worldwide with the disease.
Aldevron is "Driven by a Passion to Enable Science," as featured in the April Genetic Engineering & Biotechnology News. This article spans our new production facility in Fargo, North Dakota, and the expansion of our Freiburg, Germany, antibody facility, to our expanding CRISPR options, the publication discusses our ongoing push to help researchers in their work.
One particular highlight is the discussion of our new CRISPR options, including GMP level SpyFiTM Cas9 Nuclease and the availability of in-stock GMP level prepacked CRISPR nucleases.
This article was originally published in the October 26, 2018, edition of The Forum of Fargo-Moorhead and is republished here in its entirety.
This article was originally published in the September 23, 2018, edition of The Forum of Fargo-Moorhead and is republished here in its entirety.
We never know where roads will lead us, though one roadmap we’re proud of providing is one of internships, helping develop scientific talent in our growing biotechnology industry.
It is great to be able to provide the opportunity and watch students getting involved in the industry while being able to apply what they are learning at college to the work going on in the field.
This is a benefit to them, our company and the industry at large, as they will be the next generation of scientific talent helping drive breakthroughs in research and providing novel health care.
